Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Information void

<< Previous

Bullboard Posts

Next >>

Comment by Benedictuson Nov 18, 2023 11:14pm

188 Views

Post# 35743032

RE:RE:RE:RE:RE:RE:RE:RE:Information void

DJDawg wrote:
Sorry. Not sure for sure but I think all they are pulling in this round is 1.5 m.
So 4-6 m runway.

Yes, agreed. They are securing $1.5M. But referencing the details provided in the LIFE offering use of funds we can calculate an estimated monthly cash burn rate of $325K. So, $1.5M + working capital on hand = $2.5M/$325K nets them about 7 months, give or take.

<< Previous

Bullboard Posts

Next >>

These cold weather stocks are looking to heat up for winter